Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293046
Status:
COMPLETED
Last Update Posted:
2008-09-30
First Post:
2006-02-16
Brief Title:
Assessment of Grazax Treatment Compliance
Sponsor:
ALK-Abelló AS
Organization:
ALK-Abelló AS
Study Overview
Official Title:
A Randomised Parallel-Group Open Controlled Phase III Trial Assessing the Treatment Compliance With GRAZAX in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is performed to assess whether the Grazax treatment compliance can be improved by use of a compliance device Memozax
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None